Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals
- PMID: 12085315
- DOI: 10.1086/340637
Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals
Abstract
Antigen-specific, cytokine flow cytometry was used to analyze the prevalence and frequency of CD4 and CD8 memory T cells specific for the abundantly expressed cytomegalovirus (CMV) phosphoprotein 65 (pp65) in healthy CMV IgG-seropositive individuals. Stimulation of peripheral blood mononuclear cells with peptide pools and individual peptides derived from the pp65 amino acid sequence in 40 donors revealed that 63% of donors had a detectable CD4 T cell response and that 83% of donors had a detectable CD8 T cell response against this protein. The overall frequencies of T cells directed against pp65 were analyzed for 20 donors by stimulation with peptide pools covering the complete pp65 protein and were as high as 2 in 1000 and 9 in 1000 (median) peripheral blood CD4 and CD8 T cells, respectively. In addition, a comparison between CD4 responses to a CMV lysate containing various CMV proteins and pp65-specific responses in 9 donors indicated that pp65 was a dominant target of the CMV-specific CD4 T cell response in some, but not all, donors. Several new T cell epitopes were identified.
Similar articles
-
Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.Mol Ther. 2006 Feb;13(2):280-8. doi: 10.1016/j.ymthe.2005.08.019. Epub 2005 Oct 10. Mol Ther. 2006. PMID: 16219490
-
Human bone marrow as a source to generate CMV-specific CD4+ T cells with multifunctional capacity.J Immunother. 2009 Nov-Dec;32(9):907-13. doi: 10.1097/CJI.0b013e3181b7be60. J Immunother. 2009. PMID: 19816191
-
Rapid generation of CMV pp65-specific T cells for immunotherapy.J Immunother. 2007 Jul-Aug;30(5):557-61. doi: 10.1097/CJI.0b013e31803b945b. J Immunother. 2007. PMID: 17589296
-
Analyzing T-cell responses to cytomegalovirus by cytokine flow cytometry.Hum Immunol. 2004 May;65(5):493-9. doi: 10.1016/j.humimm.2004.02.004. Hum Immunol. 2004. PMID: 15172449 Review.
-
Cytomegalovirus (CMV)-specific cellular immune responses.Hum Immunol. 2004 May;65(5):500-6. doi: 10.1016/j.humimm.2004.02.012. Hum Immunol. 2004. PMID: 15172450 Review.
Cited by
-
Genetic analysis of cytomegalovirus in malignant gliomas.J Virol. 2012 Jun;86(12):6815-24. doi: 10.1128/JVI.00015-12. Epub 2012 Apr 11. J Virol. 2012. PMID: 22496213 Free PMC article.
-
Development of a Human Cytomegalovirus (HCMV)-Based Therapeutic Cancer Vaccine Uncovers a Previously Unsuspected Viral Block of MHC Class I Antigen Presentation.Front Immunol. 2019 Jul 30;10:1776. doi: 10.3389/fimmu.2019.01776. eCollection 2019. Front Immunol. 2019. PMID: 31417555 Free PMC article.
-
Improving cytomegalovirus-specific T cell reconstitution after haploidentical stem cell transplantation.J Immunol Res. 2014;2014:631951. doi: 10.1155/2014/631951. Epub 2014 Apr 24. J Immunol Res. 2014. PMID: 24864269 Free PMC article. Review.
-
Cotargeting EBV lytic as well as latent cycle antigens increases T-cell potency against lymphoma.Blood Adv. 2024 Jul 9;8(13):3360-3371. doi: 10.1182/bloodadvances.2023012183. Blood Adv. 2024. PMID: 38640255 Free PMC article.
-
Inconsistent reversal of HIV-1 latency ex vivo by antigens of HIV-1, CMV, and other infectious agents.Retrovirology. 2020 Nov 23;17(1):36. doi: 10.1186/s12977-020-00545-x. Retrovirology. 2020. PMID: 33228686 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials